Literature DB >> 19772269

Transconjunctival sutureless vitrectomy for the treatment of vitreoretinal complications in patients with diabetes mellitus.

Sung Jae Yang1, Sam Young Yoon, June-gone Kim, Young Hee Yoon.   

Abstract

BACKGROUND AND
OBJECTIVE: To compare the safety and effectiveness of 25-gauge transconjunctival sutureless vitrectomy (TSV) with conventional 20-gauge pars plana vitrectomy (PPV) for the treatment of vitreoretinal complications in patients with diabetic retinopathy. PATIENTS AND METHODS: Forty-five eyes of 44 consecutive patients with diabetes mellitus who had undergone 25-gauge TSV for the treatment of vitreous hemorrhage, traction retinal detachment, or diabetic macular edema and 45 control patients with diabetes mellitus who had undergone conventional 20-gauge PPV were studied.
RESULTS: The mean duration of surgery in the 25-gauge TSV group was statistically significantly shorter than that in the 20-gauge PPV group. The mean visual acuity at both 1 week and 1 month after surgery was statistically significantly better in the 25-gauge TSV group than in the 20-gauge PPV group. Complications in the 25-gauge TSV group were similar to those in the 20-gauge PPV group.
CONCLUSION: A shorter operation time and faster recovery of postoperative visual acuity were the main advantages of using 25-gauge TSV. Despite its limitations, 25-gauge TSV can be safely used for the treatment of vitreoretinal complications in patients with diabetes mellitus. Copyright 2009, SLACK Incorporated.

Entities:  

Mesh:

Year:  2009        PMID: 19772269     DOI: 10.3928/15428877-20090901-04

Source DB:  PubMed          Journal:  Ophthalmic Surg Lasers Imaging        ISSN: 1542-8877


  7 in total

1.  Outcomes of 25-gauge vitrectomy for proliferative diabetic retinopathy.

Authors:  Mahmoud Mohamed Farouk; Takeshi Naito; Khulood Mohammed Sayed; Toshihiko Nagasawa; Takashi Katome; Gamal Radwan; Ahmad Abdallah; Mohamed Elagouz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-09-17       Impact factor: 3.117

Review 2.  Current approaches to the management of diabetic retinopathy and diabetic macular oedema.

Authors:  Francesco Boscia
Journal:  Drugs       Date:  2010-11-12       Impact factor: 9.546

3.  Comparison of microinsicion vitrectomy and conventional 20-gauge vitrectomy for severe proliferative diabetic retinopathy.

Authors:  Reiji Yokota; Makoto Inoue; Yuji Itoh; Tosho Rii; Kazunari Hirota; Akito Hirakata
Journal:  Jpn J Ophthalmol       Date:  2015-07-23       Impact factor: 2.447

Review 4.  Review of Small Gauge Vitrectomy: Progress and Innovations.

Authors:  Shaheeda Mohamed; Carl Claes; Chi Wai Tsang
Journal:  J Ophthalmol       Date:  2017-05-10       Impact factor: 1.909

5.  Vitrectomy and All-Cause and Cause-Specific Mortality in Elderly Patients With Vitreoretinal Diseases: A Nationwide Cohort Study.

Authors:  Yoon Jeon Kim; Ji Sung Lee; Yunhan Lee; Hun Lee; Jae Yong Kim; Hungwon Tchah
Journal:  Front Med (Lausanne)       Date:  2022-04-25

6.  Faster recovery after 25-gauge microincision vitrectomy surgery than after 20-gauge vitrectomy in patients with proliferative diabetic retinopathy.

Authors:  Tatsuhiko Sato; Kazuyuki Emi; Hajime Bando; Toshihide Ikeda
Journal:  Clin Ophthalmol       Date:  2012-11-21

7.  Subconjunctival Injection of Viscoelastic Material for Leaking Sclerotomy in Transconjunctival Sutureless Vitrectomy.

Authors:  Chung Hyun Lee; Soo Geun Joe; Sung Jae Yang
Journal:  J Ophthalmol       Date:  2016-04-06       Impact factor: 1.909

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.